Akebia Therapeutics, Inc. Strengthens Its Leadership Team With Key Additions
1/13/2014 7:27:03 AM
Akebia Therapeutics, a biopharmaceutical company focused on the development of novel proprietary therapeutics based on hypoxia-inducible factor biology and the commercialization of these products for patients with kidney disease, today announced that it has strengthened its leadership team with two hires. Nicole R. Hadas has joined Akebia as Vice President and General Counsel, and Michel Dahan as Vice President, Commercial.
Help employers find you! Check out all the jobs and post your resume.